Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy

Sponsor
Avanir Pharmaceuticals (Industry)
Overall Status
Completed
CT.gov ID
NCT00113620
Collaborator
(none)
450
44
19.1
10.2
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether dextromethorphan (Neurodex) and quinidine are effective in the treatment of pain of diabetic neuropathy.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
450 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy
Study Start Date :
Jul 1, 2005
Actual Primary Completion Date :
Feb 1, 2007
Actual Study Completion Date :
Feb 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Pain rating scale obtained from patient diaries []

Secondary Outcome Measures

  1. Additional diary rating scales and scores obtained from clinic visits []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of diabetes mellitus

  • Established diabetic therapy for at least 3 months

  • Lab-supported diagnosis of painful diabetic distal symmetric sensory/motor polyneuropathy

  • Pain the previous three months

  • Not pregnant

Exclusion Criteria:
  • Patient failed adequate trial of 3 or more medications or has required narcotics for pain

  • History of torsades de pointes

  • Sensitivity to quinidine or opiate drugs (codeine, etc)

  • Severe pain that could confound the assessment

  • Patient has had any amputations

  • Patient has participated in the past 30 days or is currently participating in another trial

  • Patient has previously received treatment with dextromethorphan and quinidine

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pivotal Research Centers Mesa Arizona United States 85210
2 Dedicate Clinical Research, Inc. Sun City Arizona United States 85351
3 Central Arkansas Research Hot Springs Arkansas United States 71913
4 Research Solutions Jonesboro Arkansas United States 72401
5 Bay Area Foot Care Castro Valley California United States 94546
6 South Bay Clinical Research Inc. Inglewood California United States 90301
7 Pacific Sleep Medicine Services, Inc. Los Angeles California United States 90048
8 Pacific Sleep Medicine Services, Inc. Palm Springs California United States 92262
9 Northern California Research Group Sacramento California United States 95831
10 Diablo Clinical Research, Inc. Walnut Creek California United States 94598
11 Tampa Bay Medical Research Clearwater Florida United States 33761
12 University Clinical Research - DeLand DeLand Florida United States 32720
13 The Center for Diabetes and Endocrine Care Hollywood Florida United States 33021
14 FPA Clinical Research Kissimmee Florida United States 34741
15 Suncoast Neuroscience Associates, Inc. St. Petersburg Florida United States 33701
16 Neurology Clinical Research, Inc. Sunrise Florida United States 33351
17 Laszlo J. Mate, MD West Palm Beach Florida United States 33407
18 East-West Medical Research Institute Honolulu Hawaii United States 96814
19 Medisphere Medical Research Center, LLC Evansville Indiana United States 47714
20 Investigative Clinical Reserach of Indiana, LLC Indianapolis Indiana United States 46254
21 Crossroads Research, Inc. Owings Mills Maryland United States 21117
22 Medex Healthcare Research, Inc. St. Louis Missouri United States 63117
23 Radiant Research - St. Louis St. Louis Missouri United States 63141
24 Montana Neuroscience Institute Missoula Montana United States 59802
25 Creighton Diabetes Center Omaha Nebraska United States 68131
26 Advanced Biomedical Research of America Las Vegas Nevada United States 89123
27 Lovelace Scientific Resources Albuquerque New Mexico United States 87108
28 Upstate Clinical Research, LLC Albany New York United States 12205
29 DiGiovanna Family Care Center Great Neck New York United States 11021
30 Weill Medical College of Cornell University - Peripheral Neuropathy Center New York New York United States 10022
31 Vital Research Greensboro North Carolina United States 27408
32 Radiant Research Cincinnati Ohio United States 45236
33 Radiant Research - Akron Mogadore Ohio United States 44260
34 Neurology & Neuroscience Center of Ohio Toledo Ohio United States 43623
35 Knights Road Medical Bensalem Pennsylvania United States 19020
36 Omega Medical Research Warwick Rhode Island United States 02886
37 Radiant Research - Greer Greer South Carolina United States 29651
38 Radiant Research Dallas Texas United States 75231
39 Nerve & Muscle Center of Texas Houston Texas United States 77030
40 Diabetes & Glandular Disease Research Assoc. San Antonio Texas United States 78229
41 SAM Clinical Research San Antonio Texas United States 78229
42 Hampton Roads Center for Clinical Research Norfolk Virginia United States 23502
43 Tidewater Integrated Medical Research Virginia Beach Virginia United States 23451
44 University of Wisconsin Medical School Madison Wisconsin United States 53792

Sponsors and Collaborators

  • Avanir Pharmaceuticals

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00113620
Other Study ID Numbers:
  • 04-AVR-109
First Posted:
Jun 10, 2005
Last Update Posted:
Jul 14, 2016
Last Verified:
Jul 1, 2016
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 14, 2016